Overview
Updated: Aug 7, 2026
Company Overview
Boostimmune
Boostimmune develops first-in-class antibody-based therapies targeting the tumor immune microenvironment and advancing innovative approaches in oncology.
Address
Headquarters :6F, 36, Nambusunhwan-ro 350-gil, Seocho-gu, Seoul, Republic of Korea
Research Center :-
Website
Class
PharmaceuticalPartnering Goals
Private